The blood clot retrieval devices market size has grown rapidly in recent years. It will grow from $2.37 billion in 2025 to $2.78 billion in 2026 at a compound annual growth rate (CAGR) of 17.5%. The growth in the historic period can be attributed to high incidence of ischemic stroke, limited treatment options, conventional thrombectomy limitations, lack of portable devices, low adoption of imaging-guided procedures.
The blood clot retrieval devices market size is expected to see rapid growth in the next few years. It will grow to $5.25 billion in 2030 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to adoption of ai-assisted devices, growth of minimally invasive techniques, integration of real-time imaging, development of portable thrombectomy systems, expansion of specialty stroke centers globally. Major trends in the forecast period include AI-assisted thrombectomy systems, development of minimally invasive devices, enhanced catheter and stent technology, real-time imaging integration, portable blood clot removal solutions.
The increase in stroke cases is expected to drive growth in the market for blood clot retrieval devices. Stroke occurs when blood flow to part of the brain is blocked or reduced, depriving brain tissue of oxygen and nutrients. This rise in stroke is largely due to an aging population, as older individuals are more prone to hypertension and vascular issues that raise stroke risk. Blood clot retrieval devices assist stroke patients by quickly removing clots blocking brain arteries, restoring circulation and lowering the chance of permanent disability. For example, in May 2024, the Centers for Disease Control and Prevention reported approximately 795,000 strokes annually in the United States. Consequently, the growing number of stroke cases is fueling demand for blood clot retrieval devices.
Leading companies in the blood clot retrieval devices market are developing advanced products such as dual-mechanism thrombectomy systems to enhance clot removal and reduce complications during procedures. These systems combine mechanical extraction and suction techniques within one device to effectively remove both acute and chronic clots, prevent clot migration, and decrease the necessity for multiple treatments. For instance, in March 2025, Inari Medical Inc. introduced the Artix Thrombectomy System, a dual-mechanism arterial thrombectomy device designed for various arterial clots. It integrates aspiration and mechanical extraction in a single operation and includes features such as an over-the-wire mechanical component, a kink-resistant sheath with a low profile, and a covered nitinol mesh funnel to limit clot migration. This device aims to offer doctors enhanced control and flexibility, allowing efficient removal of different clot types while maintaining vessel access throughout the procedure.
In February 2025, Stryker, a medical technology company based in the United States, acquired Inari Medical for an undisclosed sum. This acquisition is intended to broaden Stryker’s interventional endovascular portfolio, increase its foothold in the expanding peripheral vascular and venous thromboembolism treatment sectors, and utilize Inari Medical’s cutting-edge mechanical thrombectomy technology to improve patient outcomes globally. Inari Medical specializes in blood clot retrieval devices.
Major companies operating in the blood clot retrieval devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Cook Medical LLC, Merit Medical Systems Inc., Penumbra Inc., Surmodics Inc., AngioDynamics Inc., B. Braun Melsungen AG, Acandis GmbH, Phenox GmbH, Rapid Medical Ltd., Argon Medical Devices Inc., Shape Memory Medical Inc., Vesalio Inc.
North America was the largest region in the blood clot retrieval devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood clot retrieval devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood clot retrieval devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the blood clot retrieval devices market by increasing costs for imported catheters, stents, and advanced thrombectomy systems, especially in regions like North America, Europe, and Asia-Pacific. Smaller hospitals and diagnostic centers experience adoption delays, while large stroke centers adapt through local sourcing or partnerships. Positive effects include incentives for domestic manufacturing of thrombectomy devices and components, potentially reducing future import dependency and fostering innovation in cost-efficient and portable solutions.
The blood clot retrieval devices market research report is one of a series of new reports that provides blood clot retrieval devices market statistics, including blood clot retrieval devices industry global market size, regional shares, competitors with a blood clot retrieval devices market share, detailed blood clot retrieval devices market segments, market trends and opportunities, and any further data you may need to thrive in the blood clot retrieval devices industry. This blood clot retrieval devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood clot retrieval devices are specialized medical tools designed to remove blood clots from blood vessels, particularly in cases of ischemic stroke. They restore normal blood flow by mechanically capturing and extracting the clot. These devices are typically employed in emergency procedures to reduce brain damage and improve patient outcomes.
The primary types of blood clot retrieval devices include mechanical embolus removal devices, Penumbra blood clot retrieval devices, stent retrievers, aspiration devices, and ultrasound-assisted devices. Mechanical embolus removal devices are minimally invasive tools that physically extract blood clots from vessels to rapidly restore blood flow. Technologies used include mechanical thrombectomy, chemical thrombectomy, ultrasound-assisted thrombectomy, and laser-assisted thrombectomy. Applications cover ischemic stroke, hemorrhagic stroke, pulmonary embolism, deep vein thrombosis, transient ischemic attack, and other types of strokes. These devices are applied in coronary arteries, peripheral arteries, and cerebral arteries. Key end users include hospitals, diagnostic centers, specialty clinics, ambulatory surgical centers, and other healthcare facilities.
The blood clot retrieval devices market consists of revenues earned by entities by providing services such as manufacturing and supplying clot retrieval devices, offering clinical training and procedural support, conducting research and technological innovation, assisting with regulatory approvals and market access. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood clot retrieval devices market also includes sales of mechanical thrombectomy devices, aspiration catheters, and stent retrievers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The blood clot retrieval devices market size is expected to see rapid growth in the next few years. It will grow to $5.25 billion in 2030 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to adoption of ai-assisted devices, growth of minimally invasive techniques, integration of real-time imaging, development of portable thrombectomy systems, expansion of specialty stroke centers globally. Major trends in the forecast period include AI-assisted thrombectomy systems, development of minimally invasive devices, enhanced catheter and stent technology, real-time imaging integration, portable blood clot removal solutions.
The increase in stroke cases is expected to drive growth in the market for blood clot retrieval devices. Stroke occurs when blood flow to part of the brain is blocked or reduced, depriving brain tissue of oxygen and nutrients. This rise in stroke is largely due to an aging population, as older individuals are more prone to hypertension and vascular issues that raise stroke risk. Blood clot retrieval devices assist stroke patients by quickly removing clots blocking brain arteries, restoring circulation and lowering the chance of permanent disability. For example, in May 2024, the Centers for Disease Control and Prevention reported approximately 795,000 strokes annually in the United States. Consequently, the growing number of stroke cases is fueling demand for blood clot retrieval devices.
Leading companies in the blood clot retrieval devices market are developing advanced products such as dual-mechanism thrombectomy systems to enhance clot removal and reduce complications during procedures. These systems combine mechanical extraction and suction techniques within one device to effectively remove both acute and chronic clots, prevent clot migration, and decrease the necessity for multiple treatments. For instance, in March 2025, Inari Medical Inc. introduced the Artix Thrombectomy System, a dual-mechanism arterial thrombectomy device designed for various arterial clots. It integrates aspiration and mechanical extraction in a single operation and includes features such as an over-the-wire mechanical component, a kink-resistant sheath with a low profile, and a covered nitinol mesh funnel to limit clot migration. This device aims to offer doctors enhanced control and flexibility, allowing efficient removal of different clot types while maintaining vessel access throughout the procedure.
In February 2025, Stryker, a medical technology company based in the United States, acquired Inari Medical for an undisclosed sum. This acquisition is intended to broaden Stryker’s interventional endovascular portfolio, increase its foothold in the expanding peripheral vascular and venous thromboembolism treatment sectors, and utilize Inari Medical’s cutting-edge mechanical thrombectomy technology to improve patient outcomes globally. Inari Medical specializes in blood clot retrieval devices.
Major companies operating in the blood clot retrieval devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, Cook Medical LLC, Merit Medical Systems Inc., Penumbra Inc., Surmodics Inc., AngioDynamics Inc., B. Braun Melsungen AG, Acandis GmbH, Phenox GmbH, Rapid Medical Ltd., Argon Medical Devices Inc., Shape Memory Medical Inc., Vesalio Inc.
North America was the largest region in the blood clot retrieval devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood clot retrieval devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood clot retrieval devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the blood clot retrieval devices market by increasing costs for imported catheters, stents, and advanced thrombectomy systems, especially in regions like North America, Europe, and Asia-Pacific. Smaller hospitals and diagnostic centers experience adoption delays, while large stroke centers adapt through local sourcing or partnerships. Positive effects include incentives for domestic manufacturing of thrombectomy devices and components, potentially reducing future import dependency and fostering innovation in cost-efficient and portable solutions.
The blood clot retrieval devices market research report is one of a series of new reports that provides blood clot retrieval devices market statistics, including blood clot retrieval devices industry global market size, regional shares, competitors with a blood clot retrieval devices market share, detailed blood clot retrieval devices market segments, market trends and opportunities, and any further data you may need to thrive in the blood clot retrieval devices industry. This blood clot retrieval devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood clot retrieval devices are specialized medical tools designed to remove blood clots from blood vessels, particularly in cases of ischemic stroke. They restore normal blood flow by mechanically capturing and extracting the clot. These devices are typically employed in emergency procedures to reduce brain damage and improve patient outcomes.
The primary types of blood clot retrieval devices include mechanical embolus removal devices, Penumbra blood clot retrieval devices, stent retrievers, aspiration devices, and ultrasound-assisted devices. Mechanical embolus removal devices are minimally invasive tools that physically extract blood clots from vessels to rapidly restore blood flow. Technologies used include mechanical thrombectomy, chemical thrombectomy, ultrasound-assisted thrombectomy, and laser-assisted thrombectomy. Applications cover ischemic stroke, hemorrhagic stroke, pulmonary embolism, deep vein thrombosis, transient ischemic attack, and other types of strokes. These devices are applied in coronary arteries, peripheral arteries, and cerebral arteries. Key end users include hospitals, diagnostic centers, specialty clinics, ambulatory surgical centers, and other healthcare facilities.
The blood clot retrieval devices market consists of revenues earned by entities by providing services such as manufacturing and supplying clot retrieval devices, offering clinical training and procedural support, conducting research and technological innovation, assisting with regulatory approvals and market access. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood clot retrieval devices market also includes sales of mechanical thrombectomy devices, aspiration catheters, and stent retrievers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Blood Clot Retrieval Devices Market Characteristics
3. Blood Clot Retrieval Devices Market Supply Chain Analysis
4. Global Blood Clot Retrieval Devices Market Trends and Strategies
5. Blood Clot Retrieval Devices Market Analysis of End Use Industries
7. Global Blood Clot Retrieval Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Blood Clot Retrieval Devices Total Addressable Market (TAM) Analysis for the Market
9. Blood Clot Retrieval Devices Market Segmentation
10. Blood Clot Retrieval Devices Market Regional and Country Analysis
11. Asia-Pacific Blood Clot Retrieval Devices Market
12. China Blood Clot Retrieval Devices Market
13. India Blood Clot Retrieval Devices Market
14. Japan Blood Clot Retrieval Devices Market
15. Australia Blood Clot Retrieval Devices Market
16. Indonesia Blood Clot Retrieval Devices Market
17. South Korea Blood Clot Retrieval Devices Market
18. Taiwan Blood Clot Retrieval Devices Market
19. South East Asia Blood Clot Retrieval Devices Market
20. Western Europe Blood Clot Retrieval Devices Market
21. UK Blood Clot Retrieval Devices Market
22. Germany Blood Clot Retrieval Devices Market
23. France Blood Clot Retrieval Devices Market
24. Italy Blood Clot Retrieval Devices Market
25. Spain Blood Clot Retrieval Devices Market
26. Eastern Europe Blood Clot Retrieval Devices Market
27. Russia Blood Clot Retrieval Devices Market
28. North America Blood Clot Retrieval Devices Market
29. USA Blood Clot Retrieval Devices Market
30. Canada Blood Clot Retrieval Devices Market
31. South America Blood Clot Retrieval Devices Market
32. Brazil Blood Clot Retrieval Devices Market
33. Middle East Blood Clot Retrieval Devices Market
34. Africa Blood Clot Retrieval Devices Market
36. Blood Clot Retrieval Devices Market Competitive Landscape and Company Profiles
37. Blood Clot Retrieval Devices Market Other Major and Innovative Companies
40. Blood Clot Retrieval Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Blood Clot Retrieval Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses blood clot retrieval devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for blood clot retrieval devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood clot retrieval devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Mechanical Embolus Removal Device; Penumbra Blood Clot Retrieval Devices; Stent Retrievers; Aspiration Device; Ultrasound Assisted Devices2) By Technology: Mechanical Thrombectomy; Chemical Thrombectomy; Ultrasound-Assisted Thrombectomy; Laser-Assisted Thrombectomy
3) By Stroke Type: Ischemic Stroke; Pulmonary Embolism; Deep Vein Thrombosis; Transient Ischemic Attack; Other Stroke Types
4) By Application: Coronary Arteries; Peripheral Arteries; Cerebral Arteries
5) By End-User: Hospitals; Diagnostic Centers; Specialty Clinics; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Mechanical Embolus Removal Device: Rotational Thrombectomy Systems; Suction Based Systems; Rheolytic Thrombectomy Systems2) By Penumbra Blood Clot Retrieval Devices: Aspiration Systems; Separator Devices; Reperfusion Catheters
3) By Stent Retrievers: Self Expanding Stent Retrievers; Retrievable Stent Systems; Balloon Expandable Stent Retrievers
4) By Aspiration Device: Large Bore Aspiration Catheters; Vacuum Assisted Aspiration Systems; Manual Aspiration Syringe Systems
6) By Ultrasound Assisted Devices: External Ultrasound Assisted Thrombolysis Systems; Catheter Directed Ultrasound Assisted Systems; Portable Ultrasound Assisted Devices
Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Becton Dickinson and Company; Stryker Corporation; Boston Scientific Corporation; Terumo Corporation; Edwards Lifesciences Corporation; Cook Medical LLC; Merit Medical Systems Inc.; Penumbra Inc.; Surmodics Inc.; AngioDynamics Inc.; B. Braun Melsungen AG; Acandis GmbH; Phenox GmbH; Rapid Medical Ltd.; Argon Medical Devices Inc.; Shape Memory Medical Inc.; Vesalio Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Blood Clot Retrieval Devices market report include:- Johnson & Johnson
- Abbott Laboratories
- Medtronic plc
- Becton Dickinson and Company
- Stryker Corporation
- Boston Scientific Corporation
- Terumo Corporation
- Edwards Lifesciences Corporation
- Cook Medical LLC
- Merit Medical Systems Inc.
- Penumbra Inc.
- Surmodics Inc.
- AngioDynamics Inc.
- B. Braun Melsungen AG
- Acandis GmbH
- Phenox GmbH
- Rapid Medical Ltd.
- Argon Medical Devices Inc.
- Shape Memory Medical Inc.
- Vesalio Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.78 Billion |
| Forecasted Market Value ( USD | $ 5.25 Billion |
| Compound Annual Growth Rate | 17.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
